Dexmedetomidine attenuates H2O2-induced cell death in human osteoblasts
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- KCI
- 저널
- JOURNAL OF DENTAL ANESTHESIA AND PAIN MEDICINE16(4) · pp.295 · 2016
- 피인용
- KCI 0
- ISSN
- 2383-9309
저자
초록
Background: Reactive oxygen species play critical roles in homeostasis and cell signaling. Dexmedetomidine, a specific agonist of the α2-adrenoceptor, has been commonly used for sedation, and it has been reported to have a protective effect against oxidative stress. In this study, we investigated whether dexmedetomidine has a protective effect against H2O2-induced oxidative stress and the mechanism of H2O2-induced cell death in normal human fetal osteoblast (hFOB) cells. Methods: Cells were divided into three groups: control group—cells were incubated in normoxia without dexmedetomidine, hydrogen peroxide (H2O2) group—cells were exposed to H2O2 (200 μM) for 2 h, and Dex/H2O2 group—cells were pretreated with dexmedetomidine (5 μM) for 2 h then exposed to H2O2 (200 μM) for 2 h. Cell viability and apoptosis were evaluated. Osteoblast maturation was determined by assaying bone nodular mineralization. Expression levels of bone-related proteins were determined by western blot. Results: Cell viability was significantly decreased in the H2O2 group compared with the control group, and this effect was improved by dexmedetomidine. The Hoechst 33342 and Annexin-V FITC/PI staining revealed that dexmedetomidine effectively decreased H2O2-induced hFOB cell apoptosis. Dexmedetomidine enhanced the mineralization of hFOB cells when compared to the H2O2 group. In western blot analysis, bone-related protein was increased in the Dex/H2O2 group. Conclusions: We demonstrated the potential therapeutic value of dexmedetomidine in H2O2-induced oxidative stress by inhibiting apoptosis and enhancing osteoblast activity. Additionally, the current investigation could be evidence to support the antioxidant potential of dexmedetomidine in vitro.
키워드
식별자
- KCI
- ART002185709



로그인
연구물 목록으로